J. METYSOVA

665 total citations
132 papers, 333 citations indexed

About

J. METYSOVA is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, J. METYSOVA has authored 132 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Organic Chemistry, 35 papers in Cellular and Molecular Neuroscience and 24 papers in Spectroscopy. Recurrent topics in J. METYSOVA's work include Synthesis and pharmacology of benzodiazepine derivatives (56 papers), Coordination Chemistry and Organometallics (38 papers) and Neuroscience and Neuropharmacology Research (34 papers). J. METYSOVA is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (56 papers), Coordination Chemistry and Organometallics (38 papers) and Neuroscience and Neuropharmacology Research (34 papers). J. METYSOVA collaborates with scholars based in Czechia. J. METYSOVA's co-authors include M. PROTIVA, E. SVATEK, J. O. Jílek, J Metys, J. HOLUBEK, A Dlabac, Ivo Jirkovsky, B. Kakáč, Miroslav Ryska and Z. J. Vejdělek and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Psychopharmacology.

In The Last Decade

J. METYSOVA

112 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. METYSOVA Czechia 9 240 61 50 34 28 132 333
N. Laxma Reddy United States 12 193 0.8× 155 2.5× 79 1.6× 23 0.7× 33 1.2× 22 348
Thaddeus R. Nieduzak United States 11 178 0.7× 117 1.9× 99 2.0× 22 0.6× 48 1.7× 16 375
Joseph P. Yevich United States 11 316 1.3× 162 2.7× 56 1.1× 21 0.6× 32 1.1× 23 450
Herbert J. Brabander United States 11 315 1.3× 108 1.8× 18 0.4× 28 0.8× 34 1.2× 20 395
G. S. Sach Italy 8 185 0.8× 113 1.9× 83 1.7× 47 1.4× 27 1.0× 14 337
Vincent A. Parrino United States 11 286 1.2× 120 2.0× 33 0.7× 18 0.5× 31 1.1× 24 444
David J. Blythin United States 13 190 0.8× 153 2.5× 95 1.9× 25 0.7× 37 1.3× 25 355
R. R. Crenshaw United States 10 220 0.9× 74 1.2× 12 0.2× 25 0.7× 34 1.2× 25 345
William B. Wright United States 16 425 1.8× 165 2.7× 29 0.6× 36 1.1× 36 1.3× 35 570
Z. J. Vejdělek Czechia 8 147 0.6× 106 1.7× 33 0.7× 23 0.7× 26 0.9× 74 245

Countries citing papers authored by J. METYSOVA

Since Specialization
Citations

This map shows the geographic impact of J. METYSOVA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. METYSOVA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. METYSOVA more than expected).

Fields of papers citing papers by J. METYSOVA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. METYSOVA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. METYSOVA. The network helps show where J. METYSOVA may publish in the future.

Co-authorship network of co-authors of J. METYSOVA

This figure shows the co-authorship network connecting the top 25 collaborators of J. METYSOVA. A scholar is included among the top collaborators of J. METYSOVA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. METYSOVA. J. METYSOVA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jílek, J. O., J. HOLUBEK, E. SVATEK, et al.. (1990). Potential antidepressant and anti-inflammatory agents: 4-(2-Propylthio)acetophenone oximes and 4-(2-propylthio)phenylalkanoic acids. Collection of Czechoslovak Chemical Communications. 55(5). 1266–1277. 1 indexed citations
4.
METYSOVA, J., et al.. (1982). Tricyclic psychotropic agents containing two chalcogen atoms in the central ring: 8-Substituted 6-(4-piperidyl)-6H-dibenz[b,e]-1,4-oxathiepins. Collection of Czechoslovak Chemical Communications. 47(11). 3077–3093. 2 indexed citations
5.
HOLUBEK, J., Miroslav Ryska, A Dlabac, et al.. (1982). Tricyclic psychotropic agents containing two chalcogen atoms in the central ring: Derivatives of 11H-dibenz[b,f]-1,4-oxathiepin. Collection of Czechoslovak Chemical Communications. 47(3). 967–983.
6.
Polívka, Zdeněk, J. HOLUBEK, E. SVATEK, J. METYSOVA, & M. PROTIVA. (1981). Fluorinated tricyclic neuroleptics: Synthesis and pharmacology of 2-chloro-8-fluoro-4-(4-methylpiperazino)-4,5-dihydrothieno[2,3-b]-1-benzothiepin. Collection of Czechoslovak Chemical Communications. 46(9). 2222–2233. 1 indexed citations
8.
METYSOVA, J., et al.. (1979). The effect of a new fluorinated tricyclic neuroleptic drug isofloxythepin on the rat striatal dopamine metabolism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(3). 130–1. 4 indexed citations
9.
HOLUBEK, J., et al.. (1977). Fluorinated tricyclic neuroleptics: 6,7-Difluoro derivative of chlorprothixene and 2-fluoro-3-hydroxy derivative of octoclothepin. Collection of Czechoslovak Chemical Communications. 42(6). 2001–2017. 2 indexed citations
10.
PROTIVA, M., et al.. (1975). Potential metabolites of perathiepin: 6-Hydroxy-10-(4-methylpiperazino)-10,11-dihydrodibenzo[b,f]thiepin and its derivatives. Collection of Czechoslovak Chemical Communications. 40(9). 2667–2675. 1 indexed citations
11.
Kakáč, B., et al.. (1973). Neurotropic and psychotropic agents. LVIII. 8-Hydroxy-10-(4-methylpiperazino)-10,11-dihydrodibenzo[b,f]thiepin, O-substitution derivatives and some related compounds. Collection of Czechoslovak Chemical Communications. 38(5). 1579–1595. 2 indexed citations
12.
METYSOVA, J., et al.. (1973). Neurotropic and psychotropic agents. LXI. Derivatives of 6-piperazinobenzo[b]pyrido[3,2-f]thiepin. Collection of Czechoslovak Chemical Communications. 38(6). 1693–1699.
13.
METYSOVA, J., et al.. (1970). Neurotropic and psychotropic compounds. XL. 2-Chloro-4-(4-methylpiperazino)-4,5-dihydrobenzo[b]thieno[3,2-f]thiepin. Collection of Czechoslovak Chemical Communications. 35(1). 378–382. 3 indexed citations
14.
SVATEK, E., et al.. (1970). Neurotropic and psychotropic substances. XLII. 2-Hydroxy-9-(3-dimethylaminopropylidene)thioxanthenes and some related compounds. Collection of Czechoslovak Chemical Communications. 35(9). 2623–2634. 2 indexed citations
15.
SVATEK, E., et al.. (1969). Metabolites of octoclothepin eliminated in human and rat urine. Biochemical Journal. 114(2). 339–342. 2 indexed citations
16.
METYSOVA, J., et al.. (1969). Neurotropic and psychotropic compounds. XXX. 4-Piperazino-4,5-dihydro-10H-benzo[a]thieno[2,3-d]cycloheptenes. Collection of Czechoslovak Chemical Communications. 34(2). 468–478. 5 indexed citations
17.
SVATEK, E., et al.. (1968). [Contribution to the biotransformation of perathiepin in vivo].. PubMed. 17(5). 248–51. 1 indexed citations
18.
Metys, J & J. METYSOVA. (1965). [Derivative of 4,9-dihydrothieno(2,3-b)benzo(e)thiepine--a new type of effective antihistaminic].. PubMed. 15(6). 871–3. 5 indexed citations
19.
METYSOVA, J., et al.. (1961). [Mebrophenhydramine and meflophenhydramine--new antihistaminics with prolonged action].. PubMed. 11. 531–8.
20.
METYSOVA, J., et al.. (1961). [Comparison of pharmacological properties of propazepine and imipramine].. PubMed. 3. 227–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026